{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025289","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.277500+00:00","generated_at":"2026-06-01T01:33:39.534063+00:00","sec_items":["3.03","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Evofem amends Series F-1 Preferred; conversion price set at $0.0154, adjustment provisions removed","bullets":["Amended Certificate of Designation removes Section 8(h) adjustment provisions from Series F-1 Preferred.","Conversion Price changed to $0.0154 per share; previously subject to adjustment.","Approved by unanimous written consent of Required Holders.","Filed with Delaware Secretary of State on June 20, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025289","json":"https://secwatch.observer/filing/0001493152-24-025289.json","markdown":"https://secwatch.observer/filing/0001493152-24-025289.md","text":"https://secwatch.observer/filing/0001493152-24-025289.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224025289/0001493152-24-025289-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224025289/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:33:39.534063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}